New psoriasis drug tackles T cells.
D000077944:Alefacept; D003365:Costs and Cost Analysis; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000191:economics / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000191:economics / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077944:Alefacept